TNFSF13 and systemic lupus erythematosus: Together, the detection of BAFF and APRIL, alongside their receptor interactions in urinary samples, highlights their potential as non-invasive biomarkers for monitoring disease progression and therapeutic response in LN, providing hope for more personalized and effective management of SLE patients.